These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22108476)

  • 1. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study.
    Appendino G; Belcaro G; Cornelli U; Luzzi R; Togni S; Dugall M; Cesarone MR; Feragalli B; Ippolito E; Errichi BM; Pellegrini L; Ledda A; Ricci A; Bavera P; Hosoi M; Stuard S; Corsi M; Errichi S; Gizzi G
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):43-9. PubMed ID: 22108476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy.
    Steigerwalt R; Nebbioso M; Appendino G; Belcaro G; Ciammaichella G; Cornelli U; Luzzi R; Togni S; Dugall M; Cesarone MR; Ippolito E; Errichi BM; Ledda A; Hosoi M; Corsi M
    Panminerva Med; 2012 Dec; 54(1 Suppl 4):11-6. PubMed ID: 23241930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study.
    Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Nargi E; Patricelli P; Bucci M
    Angiology; 2001 Oct; 52 Suppl 2():S27-31. PubMed ID: 11666119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study.
    Ledda A; Belcaro G; Dugall M; Luzzi R; Scoccianti M; Togni S; Appendino G; Ciammaichella G
    Panminerva Med; 2012 Dec; 54(1 Suppl 4):17-22. PubMed ID: 23241931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy.
    Luzzi R; Feragalli B; Belcaro G; Cesarone MR; Cornelli U; Dugall M; Hosoi M
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):51-5. PubMed ID: 22108477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cipollone G; Acerbi G; Cacchio M; Del Boccio G; Di Renzo A; Stuard S; Corsi M
    Angiology; 2006; 57(4):431-6. PubMed ID: 17022378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.
    Belcaro G; Cesarone MR; Dugall M; Pellegrini L; Ledda A; Grossi MG; Togni S; Appendino G
    Altern Med Rev; 2010 Dec; 15(4):337-44. PubMed ID: 21194249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Product evaluation of Ureadin Rx Db (ISDIN) for prevention and treatment of mild-to-moderate xerosis of the foot in diabetic patients. Prevention of skin lesions due to microangiopathy.
    Ciammaichella G; Belcaro G; Dugall M; Hosoi M; Luzzi R; Ippolito E; Cesarone MR
    Panminerva Med; 2012 Dec; 54(1 Suppl 4):35-42. PubMed ID: 23241933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, placebo-controlled, randomized study.
    Incandela L; Cesarone MR; DeSanctis MT; Belcaro G; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S11-5. PubMed ID: 12011967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elastic stockings in diabetic microangiopathy. Long-term clinical and microcirculatory evaluation.
    Belcaro G; Laurora G; Cesarone MR; Pomante P
    Vasa; 1992; 21(2):193-7. PubMed ID: 1621441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model.
    Cesarone MR; Incandela L; De Sanctis MT; Belcaro G; Bavera P; Bucci M; Ippolito E
    Angiology; 2001 Oct; 52 Suppl 2():S49-54. PubMed ID: 11666124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
    Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of a curcumin-phospholipid formulation (Meriva®) for treatment of chronic diabetic macular edema: a pilot study.
    Mazzolani F; Togni S; Giacomelli L; Eggenhoffner R; Franceschi F
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3617-3625. PubMed ID: 29917217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the local effects of vitamin E (E-Mousse) on free radicals in diabetic microangiopathy: a randomized, controlled trial.
    Ruffini I; Belcaro G; Cesarone MR; Geroulakos G; Di Renzo A; Milani M; Coen L; Ricci A; Brandolini R; Dugall M; Pomante P; Cornelli U; Acerbi G; Corsi M; Griffin M; Ippolito E; Bavera P
    Angiology; 2003; 54(4):415-21. PubMed ID: 12934761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/kidney transplantation.
    Eberl N; Piehlmeier W; Dachauer S; König A; Land W; Landgraf R
    Diabetes Metab Res Rev; 2005; 21(6):525-32. PubMed ID: 15880479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel--a placebo-controlled, randomized study.
    Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M
    Angiology; 2001 Dec; 52 Suppl 3():S35-41. PubMed ID: 11775647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aescin-based topical formulation to prevent foot wounds and ulcerations in diabetic microangiopathy.
    Hu S; Belcaro G; Dugall M; Hosoi M; Togni S; Maramaldi G; Giacomelli L
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4337-4342. PubMed ID: 27831638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
    Angiology; 2006; 57(5):569-76. PubMed ID: 17067979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.